Establishes a special commission to study and recommend ways to broaden naloxone availability without a prescription.
The bill establishes a special commission to study and develop recommendations for broadening the availability of naloxone without a prescription. The commission includes representatives from the health and human services department, insurance division, and various stakeholders. It aims to submit recommendations by May 1, 2025, to the clerks of the house and senate and the joint committee on mental health and substance abuse.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.